Surgical Science Valuation
| 0AAU Stock | 149.50 0.10 0.07% |
At this time, the company appears to be overvalued. Surgical Science Sweden has a current Real Value of USD140.6 per share. The regular price of the company is USD149.5. Our model measures the value of Surgical Science Sweden from inspecting the company fundamentals such as Operating Margin of 0.15 %, shares owned by insiders of 25.73 %, and Return On Equity of 0.0436 as well as reviewing its technical indicators and probability of bankruptcy.
Enterprise Value 6.3 B | Trailing PE 0.6823 |
Overvalued
Today
Please note that Surgical Science's price fluctuation is very steady at this time. Calculation of the real value of Surgical Science Sweden is based on 3 months time horizon. Increasing Surgical Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Surgical stock is determined by what a typical buyer is willing to pay for full or partial control of Surgical Science Sweden. Since Surgical Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgical Stock. However, Surgical Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 149.5 | Real 140.6 | Hype 148.68 | Naive 155.44 |
The intrinsic value of Surgical Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgical Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Surgical Science Sweden helps investors to forecast how Surgical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgical Science more accurately as focusing exclusively on Surgical Science's fundamentals will not take into account other important factors: Surgical Science Total Value Analysis
Surgical Science Sweden is presently projected to have takeover price of 6.32 B with market capitalization of 6.32 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Surgical Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.32 B | 6.32 B |
Surgical Science Investor Information
About 26.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Surgical Science's historical financial statements, Surgical Science Sweden is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 156.4 M | 148.9 M |
|
|
Surgical Science Asset Utilization
One of the ways to look at asset utilization of Surgical is to check how much profit was generated for every dollar of assets it reports. Surgical Science Sweden exercises its assets roughly 0.0195 %, realizing 0.0195 cents for each dollar of assets held by the company. A flourishing asset utilization indicates the company is being more effective with each dollar of assets it has. In other words, asset utilization of Surgical Science shows how effective it operates for each dollar spent on its assets.Surgical Science Profitability Analysis
The company reported the revenue of 838.25 M. Net Income was 233.97 M with profit before overhead, payroll, taxes, and interest of 531.52 M.About Surgical Science Valuation
The stock valuation mechanism determines Surgical Science's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Surgical Science Sweden based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Surgical Science. We calculate exposure to Surgical Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgical Science's related companies.Surgical Science is entity of United Kingdom. It is traded as Stock on LSE exchange.
Surgical Science Quarterly Retained Earnings |
|
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.